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Abstract 
Epidemiological studies have suggested an inverse correlation between red wine consumption 
and the incidence of cardiovascular and neurodegenerative disorders. Although white wines 
are generally low in polyphenol content as compared to red wines, Champagne wines have 
been shown to contain relatively high amounts of phenolic acids that may exert protective 
cellular actions in vivo. In this study, we have investigated the potential cardioprotective and 
neuroprotective effects of Champagne wine. Our data suggest that a daily moderate 
consumption of Champagne wine may improve vascular performance via the delivery of 
phenolic constituents capable of improving NO bioavailability and the modulation of 
metalloproteinase. Moreover, Champagne wine intervention significantly increased spatial 
working memory in aged animals, whilst no improvement was observed in presence of 
alcohol. Together, these data suggest that polyphenols present in Champagne wine may 
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Introduction 
Epidemiological studies have suggested an inverse correlation between the consumption of 
red wine and the incidence of cardiovascular disease and neurological disorders (Di 
Castelnuovo et al., 2002; Orgogozo et al., 1997). This protection, is mainly believed to be 
mediated by the ability of polyphenols present in the wine to exert anti-inflammatory 
properties (Rice-Evans and Miller, 1996) and to modulate signalling cascades that regulate 
nitric oxide production (Bastianetto, 2002) and neuronal survival (Schroeter et al., 2002). 
Although white wines are generally low in polyphenol content, in particular flavonoids, 
compared to red wines, Champagne wine has been shown to contain relatively high amounts 
of phenolic compounds (Vauzour et al., 2010). Moderate Champagne wine consumption has 
been shown to exert a number of effects in vivo, effecting peripheral serotonin and dopamine 
release (Boyer et al., 2004) and increasing plasma vitamin A concentration (Cartron et al., 
2003).  Champagne wine polyphenols have also be shown to protect cells against injury 
induced by peroxynitrite (Vauzour et al., 2007a), a physiologically relevant oxidizing species 
which has been implicated in vascular wall pathology (van der Loo et al., 2000) and 
neurodegeneration (Szabo et al., 2007).  However, thus far, there have been no studies 
investigating its consumption and changes in endothelial function and thus cardiovascular 
risk or improvement in memory. In the present studies, we have performed a human 
intervention trial in order to assess whether acute, moderate Champagne wine consumption is 
capable of modulating endothelial function in healthy human volunteers. Since improvements 
in blood flow in the brain may impact on memory in a number of ways (i.e increasing the 
delivery of oxygen to specific brain regions), we have also performed an animal study aiming 
at investigating the effects of a chronic Champagne wine intervention on spatial working 
memory. Together our data suggest that moderate Champagne wine consumption may help to 
improve both cardiovascular and dementia risks. 
Materials and Methods 
Human intervention:  The study was conducted according to the guidelines laid down in the 
Declaration of Helsinki. Fifteen healthy male and female subjects were recruited from the 
University of Reading and surrounding area. The study was designed as a single blind, 
randomized, crossover intervention trial, where volunteers were asked to consume either 375 
ml of Champagne wine (Chardonnay, Pinot Noir and Pinot Meunier, 12% alcohol) or a 
control matched for alcohol content, fruit sugars and acids. Subjects were randomly assigned 
to either the Champagne wine or control group and asked to consume the beverage within a 
10 min period.  Peripheral micro-vascular function was assessed by Laser Doppler imaging 
with iontophoresis (LDI), a validated technique which quantifies the vasodilator responses to 
1% acetylcholine (ACh, endothelium dependent vasodilatation) and 1% sodium nitroprusside 
(SNP, endothelial independent vasodilatation), delivered trans-dermally. Following a 
washout period of 28 days, volunteers returned to the unit to complete the second arm of the 
study where the procedure above was repeated. Metalloproteinase were analyzed by gelatine 
zymography as previously described (Buache et al., 2007). All biochemical parameters were 
assayed on an ILAB 600 chemistry analyzer (Instrumentation Laboratory, Warrington, UK) 
using enzyme based colorimetric tests supplied by Instrumentation Laboratory. Total 
Oxidative Capacity (TOC) was determined by a rapid enzymatic in vitro diagnostic assay 
obtained from Tatzber KEG (Höflein at the Danube, Austria). 
Animal study: 3 groups of adult, male Wistar rats (n = 8 per group; Charles-River, France) 
were housed under a 12:12 light:dark cycle. All procedures were conducted according to the 
specifications of the United Kingdom Animals (Scientific Procedures) Act, 1986.  The three 
intervention diets (placebo, ethanol 12% and Champagne wine (Chardonnay, Pinot Noir and 
Pinot Meunier, 12% alcohol)) used were analytically well characterized and contained a 
defined and characterized amount of phytochemicals and were as far as possible macro- and 
micronutrient-matched.  Rats were tested in a cross-maze apparatus as described previously 
(Williams et al., 2008). Rats were given 3 test sessions on the cross-maze, one session 
administered immediately before supplementation was started (baseline), subsequent sessions 
were administered at 3 and 6 weeks. Following completion of the test, animals were 
sacrificed and brains were removed and hippocampal and cortical regions were dissected, 
snap-frozen in liquid nitrogen and stored at –80°C until analysis.  Levels of proteins were 
assessed by Western immunoblotting as described previously (Vauzour et al., 2007b) 
 
Results and Discussion 
Champagne wine promotes endothelium-independent vascular reactivity 
Many epidemiological studies have suggested that a daily and moderate consumption of red 
or white wine is associated with a lower incidence of cardiovascular disease (Renaud and de 
Lorgeril, 1992). Many of the effects of red wine are compatible with the action of wine-
derived polyphenols on endothelium-derived nitric oxide (NO
•
) production (Flesch et al., 
1998), whilst the white wine effects may result from the synergistic actions of polyphenols 
and other phenolic constituents on LDL oxidation and platelet function (Pignatelli et al., 
2006). In the present study, we show that Champagne wine consumption is capable of 
inducing acute vascular effects and in modifying levels of specific vascular active 
components. Indeed, consumption of Champagne wine was observed to induce an acute 
change in endothelium-independent vasodilatation at 4 and 8 hours post consumption (p = 
0.045 and p = 0.037 respectively), whilst the alcohol matched control did not induce any 
changes in vascular reactivity. Although both Champagne wine (p=0.030) and the control (p= 
0.045) induced an increase in endothelium-dependent vascular reactivity at 4h, there was no 
significant difference between the vascular effects induced by Champagne wine or the 
control.  These observations are in agreement with previous studies which indicate that 
moderate alcohol is capable of inducing an acute increase in blood flow in an endothelium-
dependent manner (Tawakol et al., 2004; Vlachopoulos et al., 2003).  However, we found 
that only the Champagne wine intervention was capable of significantly inducing an increase 
in endothelium-independent vasodilatation, which was maintained up to 8h post 
consumption.  These data suggest that moderate Champagne wine consumption may enhance 
microvascular blood flow for a sustained period, through maintenance of local nitric oxide 
levels, in this case delivered via iontophoresis. These effects were also accompanied by an 
acute decrease in the concentration of matrix metalloproteinase MMP-9 (1h; p<0.05), a 
significant decrease in the plasma levels of oxidising species (6h; p<0.05) and an increase in 
urinary excretion of a number of phenolic metabolites.  In particular, the mean total excretion 
of hippuric acid, protocatechuic acid and isoferulic acid were all significantly greater 
following the Champagne wine intervention compared to control intervention (p < 0.001). 
These phenolic metabolites may affect vascular function by improving local nitric oxide 
bioavailability by two potential mechanisms.  Firstly, they may increase the local half-life of 
NO
•
 via reaction with reactive oxygen species, such as superoxide (Radi et al., 2001).  
Secondly, phenolic metabolites, such as those excreted post Champagne wine consumption, 
may mimic NADPH oxidase inhibitors (Steffen et al., 2007), such as apocynin thereby 
reducing the cellular production of superoxide and increasing the half-life of NO
•
, without 
any change in the rate of NO
•
 synthesis (Schewe et al., 2008). Our data suggest that a daily 
moderate consumption of Champagne wine may improve vascular performance via the 
delivery of phenolic constituents capable of improving nitric oxide bioavailability and 
reducing matrix metalloproteinase activity. 
Champagne wine improves working spatial memory 
Epidemiological studies have suggested that moderate wine consumption may reduce the 
incidence of certain age-related neurological disorders including Alzheimer’s disease 
(Orgogozo et al., 1997). Polyphenols may act to protect the brain in a number of ways, 
including by protection of vulnerable neurons, the enhancement of existing neuronal function 
or by stimulating neuronal regeneration (Youdim and Joseph, 2001). For example, red wine 
antioxidants were observed to protect hippocampal neurons against ethanol-induced damage 
(Assuncao et al., 2007) and a moderate consumption of Cabernet Sauvignon attenuated Aβ-
neuropathology in a mouse model of Alzheimer's disease (Wang et al., 2006). There is also a 
growing interest in the potential of polyphenols to improve memory, learning and general 
cognitive ability (Vauzour et al., 2008). In this study, we have investigated the effects of a 
chronic Champagne wine intervention on spatial working memory in aged animals (18 
months), and have determined the molecular changes in the brain underlying these 
behavioural changes.  The results indicated that Champagne wine intervention significantly 
increased spatial working memory in aged animals by 24.5 ± 3.4% (p<0.01), whilst no 
improvement was observed in presence of alcohol (p>0.05). Such observations are in 
agreement with previous studies demonstrating that chronic consumption of red wine unlike 
the ethanol solution alone, did not lead to a decline in hippocampal-dependent spatial 
memory (Assuncao et al., 2007). However, Champagne wine, which is low in flavonoids, 
was also observed to improve spatial working memory. Such effects may be the result of 
other phytochemicals such as hydroxycinnamates, phenolic acids and phenol alcohol. We 
have previously reported the beneficial effect of such molecules in primary cortical neurons 
challenged with 5-S-cysteinyl-dopamine (Vauzour et al., 2010) and peroxynitrite (Vauzour et 
al., 2007a). Moreover, for any polyphenol to exert direct neuroprotective actions they must 
also undergo permeation of the blood brain barrier (BBB), something that has been reported 
for both flavonoids and hydroxycinnamates (Youdim et al., 2004).  However, whilst the 
ability of flavonoids to cross the BBB is believed to be dependent on lipophilicity, small 
phenolics are thought to transverse the BBB via amino acid transporters, such as has been 
reported for 4-ethylcatechol (Meiergerd and Schenk, 1994).  Furthermore, caffeic acid shares 
structural similarities with L-DOPA and, as such, may undergo BBB transport via 
catecholamine transporter systems.  
In order to investigate the mechanisms underlying Champagne wine actions in the brain, we 
have assessed widespread changes in hippocampal and cortical protein expressions in 
response to the various interventions. Changes in the number of, and strength of, connections 
between neurons, via their specific interactions with the MAPK pathways, leading to an 
increase in neurotrophins such as BDNF through CREB activation were observed. It is well 
reported that flavonoids may exert cellular action by interacting with the PI 3-kinase, 
Akt/PKB and MAP kinase signalling pathways (Schroeter et al., 2002).  Smaller phenolics, 
such as caffeic acid or tyrosol, may also participate in cellular interactions of this nature 
(Nardini et al., 2000), or may directly react with toxic intermediates, as has been observed for 
p-coumaric acid (Kerry and Rice-Evans, 1999). All together, these processes act to maintain 
the number and quality of synaptic connections in the brain, a factor known to be essential for 
efficient long term potentiation (LTP), synaptic plasticity and ultimately the efficient working 
of memory.  
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